Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Rosenbloom

Showing results (81-90 of 368) with videos related to

Pageof 37
Sort By:
International Journal of Pediatric Endocrinology|February 20, 2010
Recombinant Human Insulin-Like Growth Factor-1 Treatment: Prime Time or Timeout? [Commentary on "Recombinant Human Insulin Like Growth Factor-1 Treatment: Ready for Prime Time" by Bright GM, Mendoza JR, Rosenfeld RG, Endocrinol Metab Clin N Am 2009; 38:625-38]Arlan L Rosenbloom
American Journal of Diseases of Children (1960)|October 1, 1977
Nature and nurture in the expression of diabetes mellitus and its vascular manifestationsA L Rosenbloom
Nature Clinical Practice. Endocrinology & Metabolism|October 3, 2007
Does a comprehensive rehydration regimen reduce neurologic complications associated with diabetic ketoacidosis?Arlan L Rosenbloom
Diabetologia|January 1, 1989
Diabetic thick skin and stiff jointsA L Rosenbloom
Journal of Forensic and Legal Medicine|November 19, 2013
Sudden death of a young woman attributed to diabetic ketoacidosisArlan L Rosenbloom
Acta Paediatrica (Oslo, Norway : 1992). Supplement|September 1, 1992
The chronicle of growth hormone receptor deficiency (Laron syndrome)A L Rosenbloom
Pediatric Diabetes|March 16, 2004
Fetal growth, adrenocortical function and the risk for type 2 diabetesA L Rosenbloom
The Journal of Pediatrics|September 3, 2004
Academic leadership: reflections in the key of CArlan L Rosenbloom
Lancet (London, England)|August 15, 2006
Is there a role for recombinant insulin-like growth factor-I in the treatment of idiopathic short stature?Arlan L Rosenbloom
Journal of Pediatric Endocrinology & Metabolism : JPEM|June 18, 2008
Insulin-like growth factor-I (rhIGF-I) therapy of short statureArlan L Rosenbloom
Pageof 37

Showing results (81-90 of 368) with videos related to

Sort By:
Pageof 37
International Journal of Pediatric Endocrinology|February 20, 2010
Recombinant Human Insulin-Like Growth Factor-1 Treatment: Prime Time or Timeout? [Commentary on "Recombinant Human Insulin Like Growth Factor-1 Treatment: Ready for Prime Time" by Bright GM, Mendoza JR, Rosenfeld RG, Endocrinol Metab Clin N Am 2009; 38:625-38]Arlan L Rosenbloom
American Journal of Diseases of Children (1960)|October 1, 1977
Nature and nurture in the expression of diabetes mellitus and its vascular manifestationsA L Rosenbloom
Nature Clinical Practice. Endocrinology & Metabolism|October 3, 2007
Does a comprehensive rehydration regimen reduce neurologic complications associated with diabetic ketoacidosis?Arlan L Rosenbloom
Diabetologia|January 1, 1989
Diabetic thick skin and stiff jointsA L Rosenbloom
Journal of Forensic and Legal Medicine|November 19, 2013
Sudden death of a young woman attributed to diabetic ketoacidosisArlan L Rosenbloom
Acta Paediatrica (Oslo, Norway : 1992). Supplement|September 1, 1992
The chronicle of growth hormone receptor deficiency (Laron syndrome)A L Rosenbloom
Pediatric Diabetes|March 16, 2004
Fetal growth, adrenocortical function and the risk for type 2 diabetesA L Rosenbloom
The Journal of Pediatrics|September 3, 2004
Academic leadership: reflections in the key of CArlan L Rosenbloom
Lancet (London, England)|August 15, 2006
Is there a role for recombinant insulin-like growth factor-I in the treatment of idiopathic short stature?Arlan L Rosenbloom
Journal of Pediatric Endocrinology & Metabolism : JPEM|June 18, 2008
Insulin-like growth factor-I (rhIGF-I) therapy of short statureArlan L Rosenbloom
Pageof 37